{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:05:06Z","timestamp":1791061506087,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Research"],"published-print":{"date-parts":[[2004,2]]},"DOI":"10.1016\/j.neures.2003.10.012","type":"journal-article","created":{"date-parts":[[2003,12,19]],"date-time":"2003-12-19T12:14:35Z","timestamp":1071836075000},"page":"195-202","source":"Crossref","is-referenced-by-count":145,"title":["SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Wenya","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwen","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoujian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.neures.2003.10.012_BIB1","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1073\/pnas.95.13.7659","article-title":"Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"95","author":"Ara","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1\u20132","key":"10.1016\/j.neures.2003.10.012_BIB2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(90)90576-W","article-title":"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for Parkinsonism","volume":"515","author":"Arai","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neures.2003.10.012_BIB3","doi-asserted-by":"crossref","unstructured":"Bennett, B.L., Sasaki, D.T., Murray, B.W., O\u2019Leary, E.C., Sakata, S.T., Xu, W., Leisten, J.C., Motiwala, A., Pierce, S., Satoh, Y., Bhagwat, S.S., Manning, A.M., Anderson, 2001. SP600125 an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. U.S.A. 98, 13681\u201313686.","DOI":"10.1073\/pnas.251194298"},{"key":"10.1016\/j.neures.2003.10.012_BIB4","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/exnr.1998.6906","article-title":"Chronic exposure to MPTP as a primate model of progressive Parkinsonism: a pilot study with a free radical scavenger","volume":"153","author":"Blanchet","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2003.10.012_BIB5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0092-8674(00)00116-1","article-title":"Signal transduction by the JNK group of MAP kinases","volume":"103","author":"Davis","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.neures.2003.10.012_BIB6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0092-8674(94)90380-8","article-title":"JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain","volume":"76","author":"Derijard","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.neures.2003.10.012_BIB7","doi-asserted-by":"crossref","first-page":"9126","DOI":"10.1523\/JNEUROSCI.20-24-09126.2000","article-title":"Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factoe gene transfer in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson\u2019s disease","volume":"20","author":"Eberhardt","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2003.10.012_BIB8","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/(SICI)1097-4547(19990301)55:5<620::AID-JNR9>3.0.CO;2-S","article-title":"Characterization and time-course of MPP+-induced apoptosis in human SH-SY5Y neuroblastoma cells","volume":"55","author":"Fall","year":"1999","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neures.2003.10.012_BIB9","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/ng0398-262","article-title":"A susceptibility locus for Parkinson\u2019s disease maps to chromosome 2p13","volume":"18","author":"Gasser","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neures.2003.10.012_BIB10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s004280050121","article-title":"Cellular distribution of c-Jun and c-Fos in rat lung before and after bleomycin induced injury","volume":"431","author":"Haase","year":"1997","journal-title":"Virchows. Arch."},{"key":"10.1016\/j.neures.2003.10.012_BIB11","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson\u2019s disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2003.10.012_BIB12","first-page":"19","article-title":"Biochemical pathophysiology of Parkinson\u2019s disease","volume":"45","author":"Hornykiewicz","year":"1987","journal-title":"Adv. Neurol."},{"issue":"4","key":"10.1016\/j.neures.2003.10.012_BIB13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin\u2013biotin\u2013peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.neures.2003.10.012_BIB14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminerigic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neures.2003.10.012_BIB15","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/369156a0","article-title":"The stress-activated protein kinase subfamily of c-Jun kinases","volume":"369","author":"Kyriakis","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neures.2003.10.012_BIB16","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1212\/WNL.47.6_Suppl_3.153S","article-title":"The etiology of Parkinson\u2019s disease with emphasis on the MPTP story","volume":"47","author":"Langston","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2003.10.012_BIB17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine\u2013analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neures.2003.10.012_BIB18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson\u2019s disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neures.2003.10.012_BIB19","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4684-2511-6_16","article-title":"CNS compensation to dopamine neuron loss in Parkinson\u2019s disease","volume":"90","author":"Lloyd","year":"1977","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.neures.2003.10.012_BIB20","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1523\/JNEUROSCI.19-04-01284.1999","article-title":"Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons","volume":"19","author":"Lotharius","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neures.2003.10.012_BIB21","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1074\/jbc.273.6.3756","article-title":"Dopamine induces apoptosis through an oxidation-involved SAPK\/JNK activation pathway","volume":"273","author":"Luo","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.neures.2003.10.012_BIB22","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1046\/j.1471-4159.1999.01901.x","article-title":"CEP-1347 (KT7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults","volume":"73","author":"Maroney","year":"1999","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neures.2003.10.012_BIB23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1523\/JNEUROSCI.18-01-00104.1998","article-title":"Motoneuron apoptosis is blocked by CEP-1347 (KT 7515) a novel inhibitor of the JNK signaling pathway","volume":"18","author":"Maroney","year":"1998","journal-title":"J. Neurosci."},{"issue":"8007","key":"10.1016\/j.neures.2003.10.012_BIB24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0140-6736(77)91146-1","article-title":"Success and problems of long-term levodopa therapy in Parkinson\u2019s disease","volume":"1","author":"Marsden","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.neures.2003.10.012_BIB25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/35040009","article-title":"Apoptosis in neurodegenerative disorders","volume":"1","author":"Mattson","year":"2000","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.neures.2003.10.012_BIB26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and inhibition of the ICE\/CED-3 protease necessary for mammalian apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature (London)"},{"key":"10.1016\/j.neures.2003.10.012_BIB27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0738-3991(95)00757-Q","article-title":"Parkinson\u2019s disease-medical education and psychosocial aspects","volume":"26","author":"Oertel","year":"1995","journal-title":"Patient Educ. Couns."},{"issue":"1","key":"10.1016\/j.neures.2003.10.012_BIB28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.54.1.30","article-title":"The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson\u2019s disease estimated with an unbiased stereological method","volume":"54","author":"Pakkenberg","year":"1991","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.neures.2003.10.012_BIB29","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0306-4522(01)00295-0","article-title":"Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP\/probenecid treatment","volume":"106","author":"Petroske","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neures.2003.10.012_BIB30","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","article-title":"Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease","volume":"276","author":"Polymeropoulos","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neures.2003.10.012_BIB31","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1212\/WNL.51.2_Suppl_2.S25","article-title":"Classification of fluctuations in patients with Parkinson\u2019s disease","volume":"51","author":"Quinn","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neures.2003.10.012_BIB32","first-page":"421","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neures.2003.10.012_BIB33","first-page":"1400","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenylpyridinium analogs in cultured mesencephalon: relationship to dopamine uptake affinity and inhibition of mitochondrial respiration","volume":"260","author":"Saporito","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neures.2003.10.012_BIB34","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1046\/j.1471-4159.2000.0751200.x","article-title":"MPTP activates c-Jun NH(2)-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo","volume":"75","author":"Saporito","year":"2000","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.neures.2003.10.012_BIB35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.neures.2003.10.012_BIB36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.cdd.4400449","article-title":"In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system","volume":"5","author":"Srinivasan","year":"1998","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.neures.2003.10.012_BIB37","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neures.2003.10.012_BIB38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","article-title":"Yama\/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase","volume":"81","author":"Tewari","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neures.2003.10.012_BIB39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1006\/exnr.2002.8021","article-title":"Detection of behavioral impairments correlated to neurochemical deficits in mice treated with moderate doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"178","author":"Tillerson","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neures.2003.10.012_BIB40","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1471-4159.1993.tb13610.x","article-title":"Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds","volume":"61","author":"Tipton","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neures.2003.10.012_BIB41","first-page":"363","article-title":"Experimental models of Parkinson\u2019s disease: insights from many models","volume":"49","author":"Tolwani","year":"1999","journal-title":"Lab. Anim. Sci."},{"key":"10.1016\/j.neures.2003.10.012_BIB42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-2236(98)01362-9","article-title":"Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias","volume":"22","author":"West","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neures.2003.10.012_BIB43","doi-asserted-by":"crossref","first-page":"10433","DOI":"10.1073\/pnas.181182298","article-title":"Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson\u2019s disease","volume":"98","author":"Xia","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neures.2003.10.012_BIB44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/35037739","article-title":"Apoptosis in the nervous system","volume":"407","author":"Yuan","year":"2000","journal-title":"Nature"}],"container-title":["Neuroscience Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010203003109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168010203003109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T18:16:11Z","timestamp":1704996971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168010203003109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["S0168010203003109"],"URL":"https:\/\/doi.org\/10.1016\/j.neures.2003.10.012","relation":{},"ISSN":["0168-0102"],"issn-type":[{"value":"0168-0102","type":"print"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}